江苏北人(688218) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥134,141,876.04, representing a year-on-year increase of 19.54%[5] - The net profit attributable to shareholders was ¥4,276,331.11, a significant increase of 606.54% compared to the same period last year[5] - The basic earnings per share (EPS) reached ¥0.04, reflecting a 300.00% increase from the previous year's EPS of ¥0.01[5][8] - Total revenue for Q1 2024 reached ¥134,141,876.04, an increase of 19.5% compared to ¥112,213,308.97 in Q1 2023[18] - Operating profit for Q1 2024 was ¥9,509,231.28, significantly up from ¥448,909.86 in Q1 2023[19] - Net profit for Q1 2024 was ¥6,731,710.06, compared to ¥629,073.77 in Q1 2023, marking a substantial increase[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,894,624,823.88, showing a slight increase of 1.36% from the end of the previous year[6] - Total assets as of Q1 2024 amounted to ¥1,894,624,823.88, up from ¥1,869,214,737.82 in the previous year[18] - Total liabilities for Q1 2024 were ¥938,828,918.44, slightly increased from ¥920,554,736.64 in Q1 2023[17] - Current assets totaled ¥1,410,274,492.68, a slight increase from ¥1,390,611,492.52 year-over-year[16] Cash Flow - The cash flow from operating activities was negative at -¥80,044,429.32, indicating a significant cash outflow[5] - In Q1 2024, the company reported cash inflows from operating activities of CNY 158,228,440.78, an increase of 32.3% compared to CNY 119,642,040.63 in Q1 2023[20] - The net cash outflow from operating activities was CNY -80,044,429.32, improving from CNY -88,891,676.39 in the same period last year[20] - Investment activities generated a net cash inflow of CNY 20,650,707.29, a decrease of 77.3% from CNY 90,796,153.42 in Q1 2023[21] - Cash inflows from financing activities amounted to CNY 88,588,000.00, up 64.2% from CNY 53,968,000.00 in Q1 2023[21] - The net cash flow from financing activities was CNY 25,024,074.20, an increase of 55.7% compared to CNY 16,063,658.33 in the previous year[21] - The company's cash and cash equivalents at the end of Q1 2024 were CNY 199,945,516.08, compared to CNY 55,888,797.65 at the end of Q1 2023[21] - The company experienced a net decrease in cash and cash equivalents of CNY -34,528,092.57 in Q1 2024, contrasting with an increase of CNY 17,966,153.09 in Q1 2023[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,537[13] - The largest shareholder, Zhu Zhenyou, holds 21,626,643 shares, representing 18.30% of the total shares[13] - The total number of shares held by the top 10 unrestricted shareholders includes 21,626,643 shares held by Zhu Zhenyou[14] - The company has not reported any changes in the top 10 shareholders due to securities lending activities[15] Research and Development - Research and development (R&D) expenses totaled ¥10,629,774.26, which is a decrease of 26.97% compared to the previous year[6] - Research and development expenses for Q1 2024 were ¥10,629,774.26, down from ¥14,554,503.84 in Q1 2023[19] Inventory and Receivables - The total inventory increased to ¥590,513,048.28 from ¥494,749,913.13, reflecting a growth of approximately 19.3%[15] - Accounts receivable decreased to ¥220,139,907.68 from ¥253,030,633.18, indicating a decline of about 13%[15] - The company reported trading financial assets of ¥166,892,816.67, down from ¥203,243,554.60, a decrease of approximately 17.7%[15] - The prepayments increased significantly to ¥32,952,196.56 from ¥20,920,951.07, showing a growth of about 57.5%[15] Other Information - The company reported non-recurring gains of ¥1,888,478.49, which included government subsidies and other income[7] - The company has not disclosed any new strategies or future outlook in the provided documents[15]